Journal article icon

Journal article : Letter

Bortezomib for neuromyelitis optica spectrum disorder: a new therapeutic option for the more severe forms?

Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Oxford college:
St Hilda's College
Role:
Author
More from this funder
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Funding agency for:
Irani, S
Grant:
P1201
Publisher:
American Medical Association Publisher's website
Journal:
JAMA Neurology Journal website
Volume:
75
Issue:
1
Pages:
pp 129
Publication date:
2017-11-20
DOI:
EISSN:
2168-6157
ISSN:
2168-6149
Pmid:
29159373
Source identifiers:
800471
Language:
English
Subtype:
Letter
Pubs id:
pubs:800471
UUID:
uuid:b70ef669-a242-4d69-8da6-13cc4794c372
Local pid:
pubs:800471
Deposit date:
2018-02-02

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP